• 제목/요약/키워드: Esophageal Cancer

검색결과 600건 처리시간 0.024초

Effects of Thermotherapy on Th1/Th2 Cells in Esophageal Cancer Patients Treated with Radiotherapy

  • Hong, Mei;Jiang, Zao;Zhou, Ying-Feng
    • Asian Pacific Journal of Cancer Prevention
    • /
    • 제15권5호
    • /
    • pp.2359-2362
    • /
    • 2014
  • Background: To investigate the effects of double radiofrequency hyperthermia on Th1/Th2 cells in esophageal cancer patients treated with radiotherapy. Materials and Methods: 22 patients with esophageal cancer were divided into a radiotherapy group (10 cases) and a combined group (double radiofrequency hyperthermia combined with radiotherapy group, 12 cases). Both groups received conventional radiotherapy using a cobalt-60 therapy apparatus (TD60-66Gy/30-33F). Patients in the combined group also underwent double radiofrequency hyperthermia (2F/W, 8-10F). Before and after treatment, Th1, Th2, Tc1 and Tc2 cells in peripheral blood were determined with flow cytometry. Results: In the radiotherapy group, Th1 cell contents before and after radiotherapy were $17.5{\pm}5.26%$ and $9.69{\pm}4.86%$, respectively, with a significant difference (p<0.01). The Th1/Th2 ratio was significantly decreased from $28.2{\pm}14.3$ to $16.5{\pm}10.4 $(p<0.01). In the combined group, Th1 cell content before radiotherapy was $15.9{\pm}8.18%$, and it increased to $18.6{\pm}8.84$ after radiotherapy (p>0.05), the Th1/Th2 ratio decreasing from $38.4{\pm}36.3$ to $28.1{\pm}24.0$ (p>0.05). Changes in Th2, Tc1 and Tc2 cell levels were not significant in the two groups before and after therapy (p>0.05). Conclusions: Double radiofrequency hyperthermia can promote the conversion from Th2 to Th1 cells, and regulate the balance of Th1/Th2 cells.

Experiences of thoracic esophagectomy with laparoscopic gastric pull up in thoracic esophageal cancer patient in single center

  • Jun, Jin-Woo;Kim, Wooshik;Park, Jong-Min
    • 대한종양외과학회지
    • /
    • 제14권2호
    • /
    • pp.95-101
    • /
    • 2018
  • Purpose: The standard treatment of esophageal cancer is the Ivor-Lewis operation, which consists of an abdominal phase involving gastric tube formation, and a chest phase involving esophagectomy and anastomosis. We aimed to report our experience of performing thoracic esophagectomy with the laparoscopic gastric pull up (LGPU) technique and its surgical outcomes. Methods: Clinicopathologic data and short-term surgical outcomes of 14 patients who underwent LGPU for thoracic esophageal cancer from August 2008 to May 2016 were retrospectively reviewed. Results: Mean age of the patients was 62.3 years and mean body mass index was $21.7kg/m^2$. Eleven patients had medical comorbidities. Patients' mean American Society of Anesthesiologists score was 2. Mean operation time was 428.5 minutes, with the mean abdominal operation time being 138.9 minutes. There was no open conversion case. Three patients had pneumonia, three patients had surgical site infection, and one patient had subcutaneous emphysema within 30 days after surgery. One patient had minor anastomosis site leakage. There was one 30-day mortality case. One patient with postoperative aspiration pneumonia developed acute respiratory distress disease, and died due to sepsis. Mean postoperative intensive care unit stay was 3.5 days, and mean postoperative hospital stay was 20.6 days. Nasogastric tubes were removed on average at 3.4 days, and mean oral intake time was 3.4 days. Conclusion: If the gastrointestinal surgeon has extensive experience in laparoscopic procedures, LGPU will be a safe and feasible technique for thoracic esophagectomy in patients with intrathoracic esophageal cancer.

Epidemiology of Esophageal Cancer in Yanting - Regional Report of a National Screening Programme in China

  • Wang, Xiao;Fan, Jin-Chuan;Wang, An-Rong;Leng, Yue;Li, Jun;Bao, Yu;Wang, Ying;Yang, Qing-Feng;Ren, Yu
    • Asian Pacific Journal of Cancer Prevention
    • /
    • 제14권4호
    • /
    • pp.2429-2432
    • /
    • 2013
  • Background and Objectives: Yanting in Sichuan Province is one of the highest risk areas of esophageal cancer (EC) in the world. We here summarize the epidemiology of EC in Yanting using data from the national screening programme during 2006-2011. Methods: Random cluster sampling was used to select a proportion of natural villages from six towns in Yanting, and residents aged 40-69 years old were invited for screening. Participants were screened using endoscopy with iodine staining and then confirmed by histological examinations. Results: The overall detection rates of low-grade hyperplasia (LH), moderate hyperplasia (MH), high-grade hyperplasia (HH), carcinoma in situ (CIS), intramucosal carcinoma (IC) and invasive carcinoma (INC) were 5.33%, 1.28%, 0.68%, 0.15%, 0.06% and 0.29%, respectively. The detection rates of LH, MH, HH and INC increased with age, reaching the peak among those aged 60-65 years, and the prevalences of LH and MH were higher among men than among women. In addition, the detection rates of hyperplasia were much higher in mountainous than in hilly areas. Conclusions: Among the high risk population, there are a great number of people with early-stage EC or precancerous conditions who do not have presenting symptoms. In particular, the elderly, men, or those living in mountainous areas are the most vulnerable population. It is therefore important to reinforce health education and screening services among such high risk populations.

경구경계부식도암에서 흉강경을 이용한 근치적 식도암적출술 (Thoracoscopic Radical Esophagectomy in Cervico-Thoracic Esophageal Cancer)

  • 박재길;이선희
    • Journal of Chest Surgery
    • /
    • 제29권6호
    • /
    • pp.681-688
    • /
    • 1996
  • 경구경계부 식도에 발생된 악성종양의 경우에는 진단시에 이미 식도에 밀접해 있는 기관과 주요 신경 그리고 혈관등에 침범되어 있는 경우가 많으며, 또한 외과적 절제에도 기술적인 어려움이 있어 식도암 의 발생부위중 가장 예후가 불량한 부위로 알려져 있다. 저자들은 진행형 경흥경계부 식도암 환자 1례에서 합병치료로 종양의 묶췄를 향상시킨후, 흥강경 을 이용한비개흥적 종격동 림프절적출과 경부의 림프절을 확대적출함으로써 근치도III의 고치요도술을 시행하였다. 술후 끌병증의 발병없이 식도조영술에서 양호한 조명제의 통과소견을 보였으며, 병 리 조직학적 소견상 조기식도암(TINOMO, SM2)으로 판정되어 술후 합병치료는 시행하지 않고 경과를 관찰중에 있다.

  • PDF

Intralesional steroid infusion using a spray tube to prevent stenosis after endoscopic submucosal dissection of esophageal cancer

  • Atsushi Goto;Takeshi Okamoto;Ryo Ogawa;Kouichi Hamabe;Shinichi Hashimoto;Jun Nishikawa;Taro Takami
    • Clinical Endoscopy
    • /
    • 제55권4호
    • /
    • pp.520-524
    • /
    • 2022
  • Background/Aims: Intralesional steroid injections have been administered as prophylaxis for stenosis after esophageal endoscopic submucosal dissection. However, this method carries a risk of potential complications such as perforation because a fine needle is used to directly puncture the postoperative ulcer. We devised a new method of steroid intralesional infusion using a spray tube and evaluated its efficacy and safety. Methods: Intralesional steroid infusion using a spray tube was performed on 27 patients who underwent endoscopic submucosal dissection for superficial esophageal cancer with three-quarters or more of the lumen circumference resected. The presence or absence of stenosis, complications, and the number of endoscopic balloon dilations (EBDs) performed were evaluated after treatment. Results: Although stenosis was not observed in 22 of the 27 patients, five patients had stenosis and dysphagia requiring EBD. The stenosis in these five patients was relieved after four EBDs. No complications related to intralesional steroid infusion using the spray tube were observed. Conclusions: Intralesional steroid infusion using a spray tube is a simple and safe technique that is adequately effective in preventing stenosis (clinical trial number, UMIN000037567).

HOXB7 Predicts Poor Clinical Outcome in Patients with Advanced Esophageal Squamous Cell Cancer

  • Long, Qing-Yun;Zhou, Jun;Zhang, Xiao-Long;Cao, Jiang-Hui
    • Asian Pacific Journal of Cancer Prevention
    • /
    • 제15권4호
    • /
    • pp.1563-1566
    • /
    • 2014
  • Background: Esophageal squamous cell carcinoma (ESCC) accounts for most esophageal cancer in Asia, and is the sixth common cause of cancer-related deaths worldwide. Previous studies indicated HOXB7 is overexpressed in ESCC tissues, but data on prognostic value are limited. Methods: A total of 76 advanced ESCC cases were investigated. Immunohistochemistry (IHC) was used to detect the expression levels of HOXB7 and Kaplan-Meier curves and Cox regression models to determine prognostic significance. Stratified analysis was also performed according to lymph node (LN) status. Results: Kaplan-Meier curve analysis indicated that HOXB7 positive patients had significantly shorter overall survival (OS) than HOXB7 negative patients. Multivariate analysis using the Cox proportional hazards model indicated only TNM stage and HOXB7 expression to be independent predictors of overall survival of advanced ESCC patients. HOXB7 indicated poor OS in both lymph node negative (LN-) and lymph node positive (LN+) patients. Conclusion: HOXB7 predicts poor prognosis of advanced ESCC patients and can be applied as an independent prognostic predictor.

Complete Remission of Unresectable Esophageal Cancer Achieved with Concurrent Chemoradiotherapy: A Case Report

  • Jung Min Lee;Bora Keum;Sang Yup Lee;In Kyung Yoo;Seung Han Kim;Hyuk Soon Choi;Eun Sun Kim;Hoon Jai Chun
    • Journal of Digestive Cancer Research
    • /
    • 제5권1호
    • /
    • pp.70-72
    • /
    • 2017
  • A 41-year old woman with dysphagia visited, which was aggravated after eating. On physical examination, there was a palpable mass on the left supraclavicular area. Endoscopic examination revealed a mass on the distal esophagus with irregular mucosa, erythema and a whitish plaque with luminal narrowing. The patient was diagnosed with unresectable esophageal cancer (squamous cell carcinoma, T3N2M1, Stage IV). The patient received CCRT (total 63 Gy) with cisplatin and 5-fluorouracil (5-FU). After CCRT, the patient took an additionally 2 cycles of chemotherapy for consolidation (cisplatin and 5-FU every 4 weeks). After additional chemotherapy, endoscopic examination showed no residual tumor, a chest CT scan revealed that the mass in the distal esophagus had decreased and there was no enlargement of the lymph nodes around the left supraclavicular area. The patient has been in complete remission for 5 years.

  • PDF

p16 Expression as a Surrogate Marker for HPV Infection in Esophageal Squamous Cell Carcinoma can Predict Response to Neo-Adjuvant Chemotherapy

  • Kumar, Rajeev;Ghosh, Sankar Kumar;Verma, Akalesh Kumar;Talukdar, Anuradha;Deka, Monoj Kumar;Wagh, Mira;Bahar, H.M. Iqbal;Tapkire, Ritesh;Chakraborty, Kali Pankaj;Kannan, R. Ravi
    • Asian Pacific Journal of Cancer Prevention
    • /
    • 제16권16호
    • /
    • pp.7161-7165
    • /
    • 2015
  • Background: Esophageal squamous cell carcinoma (ESCC) is a common cancer in the north east of India. The present study concerned the prevalence of human papilloma virus (HPV) in the ESCC in north eastern India and its impact on response to chemotherapy. Materials and Methods: p16 expression, a surrogate marker for HPV infection was assessed in 101 pre-treatment biopsies of locally advanced ESCC, reported from a comprehensive cancer centre in north east India, using immunohistochemistry. All patients received neo-adjuvant chemotherapy. Response was assessed clinically and histopathologically with attention to p16 expression. Results: p16 was expressed in 22% of ESCC (22 out of 101) and was more prevalent in patients who were more than 45 years of age (P=0.048). p16 positive tumors appeared more commonly in the upper 2/3 of the thoracic esophagus (18 in 22). Nine of the 22 (41%) p16 positive tumors achieved pathologic complete response following neo-adjuvant chemotherapy (P=0.008). There was a trend towards reduced mortality in this group (P=0.048). Some 9 of the 20 (45%) patients who achieved pathologic complete response were p16 positive. Conclusions: Expression of p16 in ESCC correlates with higher rate of pathologic complete remission in patients undergoing neo adjuvant chemotherapy and could be a predictive marker for response assessment.

70세 이상의 식도암 환자에시 식도절제술 및 재건술 (Esophagectomy for Esophageal Cancer in Elderly Patients Over 70 Years of Age)

  • 송석원;이현성;김문수;이종목;조재일
    • Journal of Chest Surgery
    • /
    • 제38권6호
    • /
    • pp.428-433
    • /
    • 2005
  • 식도암의 수술 시 고령은 수술 합병증 및 사망의 고위험인자로 알려져 있다. 그러나, 최근 들어 수술 술기와 수술 전후 환자 관리의 발전으로 고령의 식도암 환자에서도 식도절제술 후 합병증 및 사망률이 많이 감소하였다. 이 연구는 70세 이상의 식도암환자에서 식도절제술 및 재건술 후 결과를 70세 미만의 군과 비교 분석하고자 하였다. 대상 및 방법: 2001년 3월부터 2004년 7월까지 국립암센터 폐암센터에서 식도암으로 식도절제술 및 재건술을 시행한 174명의 환자를 대상으로 후향적 분석을 하였다 환자를 70세 이상$(제1군,\;n=27,\;15.5\%)$과 70세 미만$(제2군,\;n=147,\;84.5\%)$으로 나누어 수술전 상태, 수술 후 합병증 발생, 수술 사망 및 생존율을 비교 분석하였다. 결과 : 환자들의 연령은 평균 63_4세였으며, 남자가 159명이었다. 병리조직 소견은 $93.1\%$가 편평상피세포암이었다. 병변의 위치는 $78.8\%$에서 중부 및 하부 식도였다. 근치적 절제는 162명$(93.1\%)$에서 가능하였다 평균 재원기간은 19.4일이었으며, 두 군간에 차이는 없었다. 수술 후 합병증은 61명$(35.1\%)$에서 발생하였다. 이 중 호흡기계 합병증이 33예$(19.0\%)$로 가장 많이 발생하였다. 제1군에서 수술 전 고혈압 및 심장과 폐기능의 저하가 더 많았으나(p=0.064, p=0.002, p=0.057), 수술 후 합병증 발생률에는 두 군간에 차이가 없었다$(44.4\%\;vs.\;33.3\%,\;p=0.28)$. 수술 사망은 7명$(4.0\%)$이었으며, 두 군간에 차이가 없었다$(3.7\%\;vs.\;4.1\%)$. 평균 생존은 26.5개월로, 1년 생존율 $81.0\%$, 3년 생존율은 $40.5\%$이었고, 생존율은 두 군간에 차이가 없었다(p=0.64). 걸론: 70세 이상의 식도암 환자에서 만족스러운 조기 결과로 안전하게 식도절제술 및 재건술을 시행할 수 있었다. 따라서 고령의 식도암 환자에서도 식도 절제술 및 재건술을 적극적으로 고려해야 할 것이다.

식도질환의 외과적 치료 75례 (Surgical experience of esophageal disease: report of 75 cases)

  • 박창권
    • Journal of Chest Surgery
    • /
    • 제16권2호
    • /
    • pp.231-242
    • /
    • 1983
  • A clinical study was performed on 75 cases of the esophageal cancer and benign esophageal diseases experienced at Department of thoracic & cardiovascular surgery, School of Medicine, Keimyung University during 3 year period from 1978 to 1982. Of 75 cases of the surgical esophageal diseases, there were 35 patients of the esophageal cancer. 17 patients of benign esophageal stenosis, 10 patients of esophageal perforation, 4 patients of diverticulum. 3 patients of achalasia, 2 patients of congenital T-E fistula, one of upper esophageal web, one of esophageal foreign body, one of leiomyoma and patient of hemangioma. First, esophageal carcinoma was more frequent in men than in women by a ratio of five to one, and the peak incidence occurred in the 5th to 6th decade. Dysphagia was the most common symptom in 88.6 percent of our cases. The tumor was located mostly in the middle & the lower one third [91.4%]. The histological diagnosis was made in 35 cases. The squamous cell carcinoma was the most common [82.9%] and the rest was the adenocarcinoma in the lower one third [17.1%]. Thirty-five cases were operated and resection was feasible in the twenty-five patients [71.4%] with 2 cases of hospital mortality [5.7%]. All but two of the esophageal stenosis were caused by corrosive esophagitis and ages ranged from 7 to 70 years with average age of 32 years. Corrective operations were performed on 17 patients of esophageal stenosis of whom 12 patients had esophagocologastrostomy, 3 patients esophagogastrostomy and in non-corrosive esophageal stenosis one case and esophagoplasty and another case had release of external compression. There was one complication of stenosis of the esophageal perforation were traumatic in five cases, empyema in three cases, caustics in one case and postemetic in one case. 10 patients of the esophageal perforation underwent operation: primary closure in 5 cases, two staged colon interposition in 2, esophagogastrostomy in 1 and closed thoracotomy in 2 cases There were 2 complications of leakage of anastomosis sites in postoperative period. 4 patients of traction type of diverticulum underwent diverticulectomy & 3 patients of achalasia underwent modified Heller`s operation. 2 patients of congenital esophageal atresia had distal tracheoesophageal fistula & underwent one staged operation with the results of one death caused by pneumonia. Upper esophageal web had divulsion through the esophagoscope and foreign body in upper esophagus was removed through cervical esophagotomy. One case of leiomyoma in esophagus had esophagectomy and reconstruction with right colon. And one case of hemangioma in esophagus had esophagectomy & esophagogastrostomy.

  • PDF